A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ibrutinib Racemate | CAS 936563-87-0 - Request Quote

Picture of Ibrutinib Racemate

Ibrutinib Racemate

SZ CAT No:SZ-I005067
CAS No
936563-87-0
Mol.F.
C25H24N6O2
Mol.Wt.
440.5
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Ibrutinib Racemate is chemically 1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one. Ibrutinib Racemate is supplied with detailed characterization data compliant with regulatory guideline. Ibrutinib Racemate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ibrutinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 936563-87-0

Purchase 936563-87-0

Order 936563-87-0

Enquire 936563-87-0

price of 936563-87-0

936563-87-0 Supplier

936563-87-0 Manufacturer

936563-87-0 Exporter

buy high quality Ibrutinib Racemate

Purchase Ibrutinib Racemate

Ibrutinib Racemate suppliers

Ibrutinib Racemate manufacturers

Ibrutinib Racemate price

Order Ibrutinib Racemate

Enquire Ibrutinib Racemate

Ibrutinib Racemate cost

Ibrutinib Racemate Supplier

Ibrutinib Racemate Distributor

Ibrutinib Racemate for Method Validation

Ibrutinib Reference Standard

Ibrutinib Racemate for ANDA Filing

Ibrutinib Racemate for Forced Degradation Studies

Ibrutinib Racemate Identification Standards

Ibrutinib Racemate for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,